Anticancer siRNAs Delivered to Cells Using MOF Nanoparticles

Scientists from the University of Cambridge have developed a highly porous type of nanoparticle known as a metal-organic framework (MOF) that can deliver disease gene targeting small interfering RNAs (siRNAs) directly to cells. There...

GENcast: Explore, Learn, and Collaborate on Bioprocessing Challenges in China

/* custom css */ .td_uid_1_5d67cc6eb6488_rand { min-height: 0; } /* custom css */ .td_uid_2_5d67cc6eb66fa_rand { vertical-align: baseline; } Great symphonic music starts with the fundamental elements common to all orchestral instruments, but what separates a good...

GENcast: Explore, Learn, and Collaborate as Next-Generation Bioprocessing Moves Toward Future Horizons

/* custom css */ .td_uid_1_5d3d7246c1d42_rand { min-height: 0; } /* custom css */ .td_uid_2_5d3d7246c2001_rand { vertical-align: baseline; } We come upon the scene of a brightly lit bioproduction laboratory with a group of scientists watching their...

Anticancer Immune Cells Identified Using Antigen Receptor Barcode Tracker

Australian scientists have developed a kind of barcode tracking system for cells that can identify rare immune system cells that are produced in response to cancer. The patented Repertoire and Gene Expression by Sequencing...

Potential Diabetes Target Makes Subtle Changes with Big Impact on Metabolic Health

An enzyme that fine-tunes the structure of ceramide lipid molecules could represent a promising new target for metabolic disorders including prediabetes, diabetes, and heart disease, according to a University of Utah Health-led research team....

Potential Diabetes Target Makes Subtle Changes with Big Impact on Metabolic Health

An enzyme that fine-tunes the structure of ceramide lipid molecules could represent a promising new target for metabolic disorders including prediabetes, diabetes, and heart disease, according to a University of Utah Health-led research team....

Invitrocue Leads Market With Personalised Oncology Solutions

Invitrocue Ltd (ASX:IVQ) chief executive officer Steven Fang speaks to Proactive Investors about the oncology-focused company's development of cancer treatments by testing specific drugs on laboratory-controlled micro-tumours. "We've been able to...

GENcast: Explore, Learn, and Collaborate on Viral Safety in Biomanufacturing

Ask the average person on the street what they think of after hearing the phrase viral safety, and you will most likely be regaled with stories about scientists in hazmat suits saving Matt Damon...

Stay connected

48,188FollowersFollow
14,700SubscribersSubscribe

Recent posts

Random article